USA Financial Portformulas Corp lessened its stake in shares of Masimo Corporation (NASDAQ:MASI) by 7.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,572 shares of the medical equipment provider’s stock after selling 1,390 shares during the period. USA Financial Portformulas Corp’s holdings in Masimo Corporation were worth $1,434,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Fortaleza Asset Management Inc. bought a new position in Masimo Corporation during the 2nd quarter valued at approximately $106,000. Dubuque Bank & Trust Co. increased its position in Masimo Corporation by 3.4% during the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after buying an additional 61 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Masimo Corporation by 13.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock valued at $184,000 after buying an additional 236 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new position in Masimo Corporation during the 2nd quarter valued at approximately $203,000. Finally, Advisor Group Inc. increased its position in Masimo Corporation by 38.4% during the 2nd quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 655 shares in the last quarter. 83.94% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY WARNING: This piece was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/11/08/usa-financial-portformulas-corp-has-1-43-million-position-in-masimo-corporation-masi.html.
A number of research firms recently weighed in on MASI. BidaskClub lowered Masimo Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Monday, August 14th. Stifel Nicolaus reiterated a “buy” rating and set a $108.00 target price on shares of Masimo Corporation in a research note on Friday, November 3rd. Zacks Investment Research upgraded Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 target price on the stock in a research note on Thursday, November 2nd. Finally, Roth Capital increased their target price on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. Masimo Corporation currently has an average rating of “Hold” and an average target price of $97.17.
In other news, EVP Yongsam Lee sold 5,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total value of $449,450.00. Following the transaction, the executive vice president now directly owns 74,000 shares in the company, valued at approximately $6,651,860. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total value of $900,000.00. Following the completion of the transaction, the director now owns 73,249 shares in the company, valued at $6,592,410. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 26,000 shares of company stock worth $2,309,200. Company insiders own 13.10% of the company’s stock.
Shares of Masimo Corporation (NASDAQ MASI) traded up $0.65 on Wednesday, reaching $88.40. The company’s stock had a trading volume of 110,258 shares, compared to its average volume of 398,200. Masimo Corporation has a 1-year low of $57.31 and a 1-year high of $104.71. The stock has a market cap of $4,488.15, a P/E ratio of 33.28, a price-to-earnings-growth ratio of 2.92 and a beta of 0.75.
Masimo Corporation (NASDAQ:MASI) last issued its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the consensus estimate of $0.53 by $0.17. The business had revenue of $193.69 million for the quarter, compared to the consensus estimate of $189.01 million. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. The company’s revenue was up 15.6% compared to the same quarter last year. During the same period last year, the business posted $0.52 EPS. research analysts forecast that Masimo Corporation will post 2.96 earnings per share for the current year.
Masimo Corporation Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.